ArticleDer Nervenarzt2025
[Update on obsessive-compulsive and related disorders].
Article in Der Nervenarzt, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Disturbances in time perception in patients with obsessive-compulsive disorder.European archives of psychiatry and clinical neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obsessive-compulsive disorders (OCD) are common and have high treatment resistance rates. The rationale of this CME article is to provide an update on OCD in adulthood. First, recent study results on the etiopathogenesis of OCD and its correlates are summarized and the clinical manifestations and current classification criteria are presented. Insight specifiers were added in the ICD-11 criteria and the classification into subtypes and the time criterion were removed; instead, the criteria now require the symptoms to be time-consuming (e.g., lasting > 1 h/day). In addition, a separate category for obsessive-compulsive and related disorders has been introduced. Frequent mental comorbidities, which are present in approximately 70-90% of cases and differential diagnostic considerations are summarized. The current state with respect to the diagnostic work-up and secondary (e.g., autoimmune) obsessive-compulsive syndromes is outlined. In terms of treatment options, disorder-specific cognitive behavioral therapy with exposure and response prevention has demonstrated high effect sizes. Novel approaches and formats include concentrated short-term or internet-based interventions. Pharmacotherapy is primarily carried out with serotonin reuptake inhibitors (SSRIs or clomipramine). Atypical antipsychotic drugs can be used for augmentation. Glutamate modulators are currently being investigated in clinical trials. Brain stimulation techniques, including noninvasive repetitive transcranial magnetic stimulation and invasive bilateral deep brain stimulation, are therapeutic options in cases of treatment resistance. Finally, a short summary delineates other OCD-related disorders. New diagnostic and treatment options to reduce the treatment resistance rates seem promising.
Indexed as
Identifiers
40576724What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.